iBio Reports Progress on its Bio-Better Rituximab Collaboration with CC-Pharming
December 16, 2019 16:15 ET
|
iBio, Inc.
- Presentation Demonstrates Advantages of iBio’s Recently Launched FastGlycaneering Development Service™ - NEW YORK, Dec. 16, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) presented...
iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan
December 13, 2019 17:00 ET
|
iBio, Inc.
NEW YORK, Dec. 13, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE American: IBIO) (“iBio” or the “Company”), a leader in plant-based biologics manufacturing, announced today that on December 9, 2019, the...
iBio Introduces FastGlycaneering Development Service™ to Power Recombinant Protein Production
December 10, 2019 16:44 ET
|
iBio, Inc.
NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today unveiled the FastGlycaneering Development Service™, which includes an array of new glycosylation technologies for...
iBio Joins Manufacturing USA’s Tissue Biofabrication Initiative
December 03, 2019 12:31 ET
|
iBio, Inc.
NEW YORK, Dec. 03, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced that it is now part of a new public-private Manufacturing USA initiative, the Advanced Regenerative...
iBio to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference
December 02, 2019 16:15 ET
|
iBio, Inc.
NEW YORK, Dec. 02, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) announced today that management will present an update on the Company’s business at the first annual BioTuesdays Pre-JPM...
iBio, Inc. Prices $5,000,000 Public Offering
October 25, 2019 08:30 ET
|
iBio, Inc.
NEW YORK, Oct. 25, 2019 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN: IBIO) (“IBIO” OR THE “COMPANY”), today announced the pricing of an underwritten public offering with expected total gross...
iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan
October 22, 2019 16:30 ET
|
iBio, Inc.
NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN: IBIO) (“IBIO” OR THE “COMPANY”) announced today that on October 16, 2019, the Company received notice from NYSE American (the...
iBio’s Collaboration with South Africa’s AzarGen Biotechnologies Advances to Next Stage
September 17, 2019 16:15 ET
|
iBio, Inc.
NEW YORK, Sept. 17, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”) today announced that it has entered into the initial Statement of Work (“SOW1”) under its...
iBio and CC-Pharming Expand Business Collaboration in China
August 26, 2019 17:30 ET
|
iBio, Inc.
NEW YORK, Aug. 26, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced that it has expanded the scope of its business venture with CC-Pharming Ltd. by granting it an exclusive,...
iBio Inks 3D Bioprinting Agreement
August 19, 2019 16:35 ET
|
iBio, Inc.
NEW YORK, Aug. 19, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced that it has entered into a Master Services Agreement (“MSA”) with Lung Biotechnology PBC, a subsidiary of...